MEST is an imprinted gene that is transcribed from the paternal allele in both mice and humans, at least during early developmental stages . The protein contains an α/β hydrolase fold characteristic of many enzymatic proteins, suggesting a potential catalytic function that remains to be fully characterized . In mice, Mest protein has been identified as an approximately 53-kDa protein through immunoblotting analysis with anti-Mest protein antibodies .
Expression analysis reveals that MEST was originally identified as highly abundant in the mesoderm and its derivatives . In adipose tissue specifically, MEST expression levels have been shown to correlate closely with accumulated fat mass in various mouse depots .
In normal development, MEST plays roles in mesodermal differentiation and is subject to imprinting regulations. During pathological states such as obesity, MEST expression is significantly upregulated in white adipose tissue (WAT) . This upregulation appears to be dynamically regulated between individuals with varying weight gain profiles, despite identical genetic backgrounds in experimental models .
Studies have demonstrated that MEST expression is promoted by diets high in both unsaturated and saturated fats, while this induction can be prevented when animals are simultaneously exposed to cold stress conditions (4°C), which typically prevents diet-induced weight gain .
One of the most intriguing aspects of MEST biology is the seemingly contradictory relationship between its expression and function in adipogenesis. While MEST expression increases during human adipocyte differentiation and correlates positively with adipocyte volume in obese states , functional studies reveal an unexpected inverse relationship with adipogenic capacity.
Knockdown of MEST during human adipocyte differentiation results in increased lipid accumulation and enhanced expression of adipocyte marker genes . Conversely, overexpression of MEST reduces human adipocyte differentiation . This apparent paradox suggests that MEST may function as a negative regulator of adipogenesis despite being upregulated during this process, possibly as part of a feedback mechanism to control excessive adipocyte expansion.
Microarray analysis following MEST knockdown has revealed significant promotion of PPAR signaling and glycolysis pathways . This suggests that MEST may normally function to suppress these pathways, which are known to promote adipogenesis.
Interestingly, knockdown of MEST has been shown to fully substitute for the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX) as an inducer of adipogenesis . This indicates that MEST may be involved in cAMP-dependent signaling pathways that regulate the early stages of adipocyte differentiation.
Transgenic mouse models have provided valuable insights into MEST function in vivo. Mice overexpressing Mest in the adipogenic lineage display an enlargement of adipocyte size , consistent with MEST's correlation with adiposity. In contrast, global Mest knockout mice exhibit reduced adiposity .
Based on current research, the 3T3-L1 mouse preadipocyte cell line has been effectively used to study MEST function in adipogenesis . This established model allows for:
Transfection of expression vectors or siRNA for MEST
Selection of stable transformants using neomycin resistance
Comparison of adipogenic potential between MEST-modified and control cells
Analysis of molecular pathways affected by MEST alterations
Researchers should maintain these cells in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% Calf serum (CS) at 37°C in the presence of 5% CO₂ .
For optimal transfection of MEST expression vectors into preadipocyte cell lines like 3T3-L1, the following protocol has proven effective:
Seed 5 × 10⁵ cells onto 60-mm dishes one day prior to transfection in DMEM supplemented with 10% CS
Treat cells with a complex of Lipofectamine 3000 and 5 μg of plasmid DNA
After 24 hours of incubation, trypsinize cells and seed into 100-mm dishes
This method allows for the establishment of stable cell lines expressing recombinant MEST for long-term studies of its effects on adipocyte differentiation and function.
To verify successful expression of recombinant MEST in experimental models, researchers should employ both mRNA and protein detection methods:
RNA analysis: Quantitative RT-PCR can be used to measure MEST mRNA levels, comparing expression between transfected cells and appropriate controls
Protein detection: Immunoblotting with specific anti-MEST antibodies can confirm protein expression, with expected detection of approximately 53-kDa band corresponding to the MEST protein
Visual representation of expression differences, as demonstrated in Figure 1 of the referenced study , provides clear evidence of successful MEST manipulation.
While not specifically focused on MEST, recent advances in transcriptomic technology offer powerful approaches for studying MEST-regulated pathways:
High-throughput real-time PCR systems: Enable analysis of multiple genes simultaneously in large sample numbers
RNA sequencing (RNA-seq): Performs massive measurements of the transcriptome for comprehensive pathway analysis
Microarrays: Allow targeted analysis of specific gene sets affected by MEST manipulation
These technologies have already demonstrated value in related fields, as shown in studies detecting transcriptomic changes in response to recombinant bovine somatotropin (rbST) in dairy cattle .
For researchers studying MEST function in vivo, particularly in adipose tissue, several approaches have proven effective:
Direct tissue analysis: Post-mortem analysis of adipose tissue provides comprehensive insights but is limited in longitudinal studies
Cell isolation from tissues: Similar to milk somatic cells used in other studies, isolation of specific cell populations from adipose tissue allows examination of MEST effects in specific cell types while minimizing invasive procedures
Multiple time-point sampling: Collection of samples at different timepoints throughout experimental interventions enables tracking of MEST expression dynamics in response to dietary or pharmacological treatments
The apparent paradox that MEST expression increases during adipogenesis while functionally inhibiting this process requires careful interpretation. Researchers should consider:
Temporal dynamics: MEST may have different functions at different stages of adipocyte differentiation
Feedback mechanisms: Increased MEST expression may represent a compensatory response to limit excessive adipogenesis
Context-dependent effects: MEST function may vary depending on the metabolic state, species, or specific adipose depot being studied
While the search results don't specifically address production of recombinant bovine MEST, researchers can apply principles from other recombinant protein production systems:
Expression system selection: Bacterial, yeast, insect, or mammalian expression systems each offer advantages for different research applications
Protein folding considerations: The α/β hydrolase fold of MEST requires proper folding for functional studies, which may necessitate eukaryotic expression systems
Purification strategy: Design of purification protocols must account for MEST's biochemical properties and potential enzymatic activity
Despite the α/β hydrolase fold suggesting enzymatic activity, MEST's specific catalytic function remains unidentified. Researchers should consider:
Substrate screening: Systematic testing of potential substrates relevant to lipid metabolism, given MEST's association with adiposity
Structure-function analysis: Site-directed mutagenesis of putative catalytic residues to identify those essential for function
Proteomics approaches: Identification of MEST-interacting proteins that may provide clues to its biochemical function